Navigator grows 14% in the tissue segment during the first nine months of 2025

The Navigator Company released its results for the first nine months of 2025, highlighting the strong performance of its tissue business. Sales reached 177,000 tons, marking a 14% growth in volume and 17% in value compared to the same period last year.

According to the company, this growth was driven by the integration of Navigator Tissue UK, completed in May 2024, which contributed to expanding the product range, diversifying the customer base, and generating synergies.

International tissue sales accounted for about 80% of total volume, up from 54% in 2022. The main markets were the United Kingdom (35%), Spain (30%), and France (14%). The finished products segment represented 98% of sales, while parent reels accounted for the remaining 2%.

Regarding sales channels, the At Home/Consumer market represented approximately 83% of total sales, while the Away From Home segment accounted for 17%. The report also noted that tissue production costs reached “the second-lowest value since mid-2021,” reflecting improved operational efficiency.

For the company as a whole, total sales from January to September 2025 amounted to €1.489 billion, with an EBITDA of €300.2 million, corresponding to a margin of 20.2%.